Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission

Journal of Medical Virology

Volumn 78, Issue 7, 2006, Pages 911-914

  Indolfi, Giuseppe ^a   Azzari, Chiara ^a   Moriondo, Maria ^a   Lippi, Francesca ^a   De Martino, Maurizio ^a   Resti, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Disease activity; Infection; Mother to child transmission; Risk factor

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EVALUATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS C; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; RNA, VIRAL; TIME FACTORS;

HEPATITIS C VIRUS;

EID: 33744963728     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20640     Document Type: Article

References (29)

1. Asselah T, Martinot M, Cazals-Hatem D, Boyer N, Auperin A, Le Breton V, Erlinger S, Degott C, Valla D, Marcellin P. 2002. Hypervariable region I quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels. J Viral Hepat 9:29-35.
2. Azzari C, Resti M, Moriondo M, Ferrari R, Lionetti P, Vierucci A. 2000. Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 96:2045-2048.
3. Bortolotti F, Resti M, Giacchino R, Crivellaro C, Zancan L, Azzari C, Gussetti N, Tasso L, Faggion S. 1998. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr 133:378-381.
4. Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, Mautone A, Impedovo L, Ierardi E, Mastroianni M, Bettocchi S, Selvaggi L. 2001. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: A 24-month prospective study. J Pediatr Gastroenterol Nutr 33:570-575.
5. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. 2000. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31:751-755.
6. Galli L, Tovo PA, de Martino M, Gabbiano C, Mannelli F, Palomba E, Vierucci A. 1993. Impact of infection status in the father on the rate of HIV-1 transmission from an infected mother to her child. Fed AIDS HIV Infect Fetus Adolesc 4:425-428.
7. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, Butler K. 2000. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 356:904-907.
8. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. 1997. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 25:697-701.
9. Jamal MM, Soni A, Quinn PG, Wheeler DE, Arora S, Johnston DE. 1999. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 30:1307-1311.
10. Kudo T, Yanase Y, Ohshiro M, Yamamoto M, Morita M, Shibata M, Morishima T. 1997. Analysis of mother-to-infant transmission of hepatitis C virus: Quasispecies nature and buoyant densities of maternal virus populations. J Med Virol 51:225-230.
11. Kurosaki M, Enomoto N, Marumo F, Sato C. 1993. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 18:1293-1299.
12. Kurosaki M, Enomoto N, Marumo F, Sato C. 1995. Variations in the core region of hepatitis C virus genomes in patients with chronic hepatitis. Arch Virol 140:1087-1094.
13. Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, Levy S, Degott C, Valla DC, Marcellin P. 2001. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology 34:1000-1005.
14. Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, Cazier A, Huraux JM, Devergie B, Vidaud M, Opolon P, Poynard T. 1998. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 27:868-872.
15. Nagayama K, Kurosaki M, Enomoto N, Maekawa SY, Miyasaka Y, Tazawa J, Izumi N, Marumo F, Sato C. 1999. Time-related changes in full-length hepatitis C virus sequences and hepatitis activity. Virology 263:244-253.
16. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A. 1994. Transmission of hepatitis C virus from mothers to infants. The vertical transmission of hepatitis C virus Collaborative Study Group. N Engl J Med 330:744-750.
17. Okamoto M, Nagata I, Murakami J, Kaji S, Iitsuka T, Hoshika T, Matsuda R, Tazawa Y, Shiraki K, Hino S. 2000. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: High virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 182:1511-1514.
18. Pasquier C, Cayrou C, Blancher A, Tourne-Petheil C, Berrebi A, Tricoire J, Puel J, Izopet J. 1998. Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1. J Virol 72:8493-8501.
19. Pitt J, Brambilla D, Reichelderfer P, Landay A, McIntosh K, Burns D, Hillyer GV, Mendez H, Fowler MG. 1997. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: Findings from the women and infants transmission study. J Infect Dis 175:567-575.
20. Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, Badalamenti S, Trepo C. 2002. Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology 36:973-977.
21. Rehermann B. 2000. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 20:127-141.
22. Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, de Martino M, Vierucci A. 1998. Mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 317:437-441.
23. Resti M, Azzari C, Galli L, Zuin G, Giacchino R, Bortolotti F, Marcellini M, Moriondo M, de Martino M, Vierucci A, Italian Study Group on Mother-to-Infant Hepatitis C Virus Transmission. 2002a. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: Results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 185:567-572.
24. Resti M, Azzari C, Moriondo M, Betti L, Sforzi I, Novembre E, Vierucci A. 2002b. Injection drug use facilitates hepatitis C virus infection of peripheral blood mononuclear cells. Clin Infect Dis 35:236-239.
25. Shiffman ML, Stewart CA, Hofmann CM, Contos MJ, Luketic VA, Sterling RK, Sanyal AJ. 2000. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: Comparison of hepatic histology and response to interferon therapy. J Infect Dis 182:1595-1601.
26. Sylvestre DL, Clements BJ. 2004. The utility of indirect predictors of hepatitis C viremia. Drug Alcohol Depend 74:15-19.
27. Tovo PA, Palomba E, Ferraris G, Principi N, Ruga E, Dallacasa P, Maccabruni A. 1997. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV infection in children. Clin Infect Dis 25:1121-1124.
28. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr P, Miyamura T, Mc Hutchinson J, Houghton M. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA 89:3468-3472.
29. Yuki N, Hayashi N, Moribe T, Matsushita Y, Tabata T, Inoue T, Kanazawa Y, Ohkawa K, Kasahara A, Fusamoto H, Kamada T. 1997. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 25:439-444.